Pratteln, Switzerland, February 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE® ...
The president and CEO of the Muscular Dystrophy Association talks about what she's most excited about in neuromuscular ...
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript March 5, 2026 REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.3 EPS, expectations were $-1.01. Operator: Thank you for ...
Horses are just as much a part of New Mexico’s story as green chile and balloons. One local startup is hoping their research ...
He was born more than 100 years ago and died more than 30 years ago, but his life and work remain relevant. “He’s timeless — ...
Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:30 PM EDTCompany ParticipantsRichard John Daly ...
ELMIRA, N.Y. (WETM)— Last week, Eric Dane passed away from ALS, also known as Lou Gehrig’s disease. He publicly shared his ...
Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...
LVEF (Left Ventricular Ejection Fraction): Percentage measure of how much blood the left ventricle pumps out with each ...
Cumberland to highlight 2025 financial, international, portfolio and clinical progressNASHVILLE, Tenn., March 3, 2026 /PRNewswire/ -- Cumberland ...
Early diagnosis of rare diseases in children can significantly improve treatment outcomes and quality of life. Learn symptoms, challenges, and why early detection is crucial for managing pediatric ...
Cumberland to highlight 2025 financial, international, portfolio and clinical progress NASHVILLE, Tenn., March 3, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.